{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:58:19Z","timestamp":1790909899609,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00210-022-02234-2","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:03:56Z","timestamp":1648717436000},"page":"741-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways"],"prefix":"10.1007","volume":"395","author":[{"given":"Usman","family":"Sabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-2072","authenticated-orcid":false,"given":"Hafiz Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alamgeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihtisham","family":"Umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid Rasul","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad Mazhar","family":"Asjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"issue":"23","key":"2234_CR1","doi-asserted-by":"publisher","first-page":"36984","DOI":"10.18632\/oncotarget.16974","volume":"8","author":"J Ahn","year":"2017","unstructured":"Ahn J, Lee H, Jung CH, Choi WH, Ha TY (2017) Zerumbone ameliorates high-fat diet-induced adiposity by restoring AMPK-regulated lipogenesis and microRNA-146b\/SIRT1-mediated adipogenesis. Oncotarget 8(23):36984","journal-title":"Oncotarget"},{"issue":"10","key":"2234_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ptr.5667","volume":"30","author":"M Akhlaghi","year":"2016","unstructured":"Akhlaghi M (2016) Non-alcoholic fatty liver disease: beneficial effects of flavonoids. Phytother Res 30(10):1559\u20131571","journal-title":"Phytother Res"},{"issue":"11","key":"2234_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jnutbio.2013.06.003","volume":"24","author":"PVA Babu","year":"2013","unstructured":"Babu PVA, Liu D, Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 24(11):1777\u20131789","journal-title":"J Nutr Biochem"},{"key":"2234_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","volume":"130","author":"M Bagherniya","year":"2018","unstructured":"Bagherniya M, Nobili V, Blesso CN, Sahebkar A (2018) Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review. Pharmacol Res 130:213\u2013240","journal-title":"Pharmacol Res"},{"issue":"4","key":"2234_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 56(4):952\u2013964","journal-title":"J Hepatol"},{"issue":"1","key":"2234_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG (2019) Molecular pathways of nonalcoholic fatty liver disease development and progression. Cel Mol Life Sci 76(1):99\u2013128","journal-title":"Cel Mol Life Sci"},{"issue":"8","key":"2234_CR7","doi-asserted-by":"publisher","first-page":"e104321","DOI":"10.1371\/journal.pone.0104321","volume":"9","author":"C Bumke-Vogt","year":"2014","unstructured":"Bumke-Vogt C, Osterhoff MA, Borchert A, Guzman-Perez V, Sarem Z, Birkenfeld AL, B\u00e4hr V, Pfeiffer AF (2014) The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells. PLoS One 9(8):e104321","journal-title":"PLoS One"},{"issue":"4","key":"2234_CR8","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1016\/j.cub.2007.01.008","volume":"17","author":"ME Carter","year":"2007","unstructured":"Carter ME, Brunet A (2007) FOXO transcription factors. Curr Biol 17(4):R113\u2013R114","journal-title":"Curr Biol"},{"issue":"20","key":"2234_CR9","doi-asserted-by":"publisher","first-page":"13296","DOI":"10.1074\/jbc.C800241200","volume":"284","author":"P Chakrabarti","year":"2009","unstructured":"Chakrabarti P, Kandror KV (2009) FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem 284(20):13296\u201313300","journal-title":"J Biol Chem"},{"key":"2234_CR10","doi-asserted-by":"publisher","first-page":"105298","DOI":"10.1016\/j.phrs.2020.105298","volume":"163","author":"T-C Chang","year":"2021","unstructured":"Chang T-C, Chiou W-C, Lai W-H, Huang H-C, Huang Y-L, Liu H-K, Liang Y-C, Huang C (2021) Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK\/AKT signaling pathway. Pharmacol Res 163:105298","journal-title":"Pharmacol Res"},{"key":"2234_CR11","doi-asserted-by":"crossref","unstructured":"Chao HW, Chao SW, Lin H, Ku HC, Cheng CF\u00a0(2019) Homeostasis of glucose and lipid in non-alcoholic fatty liver disease. Int J Mol Sci 20(2):298","DOI":"10.3390\/ijms20020298"},{"key":"2234_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.biopha.2017.09.093","volume":"97","author":"H-J Chen","year":"2018","unstructured":"Chen H-J, Liu J (2018) Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant. Biomed Pharmacother 97:1386\u20131396","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2234_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jfda.2018.01.005","volume":"26","author":"J-W Chen","year":"2018","unstructured":"Chen J-W, Kong Z-L, Tsai M-L, Lo C-Y, Ho C-T, Lai C-S (2018) Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells. J Food Drug Anal 26(3):1075\u20131085","journal-title":"J Food Drug Anal"},{"key":"2234_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jff.2014.02.019","volume":"9","author":"Y-C Chen","year":"2014","unstructured":"Chen Y-C, Kao T-H, Tseng C-Y, Chang W-T, Hsu C-L (2014) Methanolic extract of black garlic ameliorates diet-induced obesity via regulating adipogenesis, adipokine biosynthesis, and lipolysis. J Funct Foods 9:98\u2013108","journal-title":"J Funct Foods"},{"key":"2234_CR15","doi-asserted-by":"publisher","first-page":"172922","DOI":"10.1016\/j.ejphar.2020.172922","volume":"870","author":"C Cheng","year":"2020","unstructured":"Cheng C, Li Z, Zhao X, Liao C, Quan J, Bode AM, Cao Y, Luo X (2020) Natural alkaloid and polyphenol compounds targeting lipid metabolism: treatment implications in metabolic diseases. Eur J Pharmacol 870:172922","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2234_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/ars.2010.3370","volume":"14","author":"Z Cheng","year":"2011","unstructured":"Cheng Z, White MF (2011) Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 14(4):649\u2013661","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"2234_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3945\/jn.111.150052","volume":"142","author":"J Chung","year":"2012","unstructured":"Chung J, Koo K, Lian F, Hu KQ, Ernst H, Wang X-D (2012) Apo-10\u2019-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob\/ob mice. J Nutr 142(3):405\u2013410","journal-title":"J Nutr"},{"issue":"1","key":"2234_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2017.0039","volume":"24","author":"H Dhami-Shah","year":"2018","unstructured":"Dhami-Shah H, Vaidya R, Udipi S, Raghavan S, Abhijit S, Mohan V, Balasubramanyam M, Vaidya A (2018) Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis. Clin Mol Hepatol 24(1):77","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"2234_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.livres.2017.11.004","volume":"1","author":"XC Dong","year":"2017","unstructured":"Dong XC (2017) FOXO transcription factors in non-alcoholic fatty liver disease. Liver Research 1(3):168\u2013173","journal-title":"Liver Research"},{"key":"2234_CR20","doi-asserted-by":"publisher","first-page":"173145","DOI":"10.1016\/j.ejphar.2020.173145","volume":"880","author":"Z Dong","year":"2020","unstructured":"Dong Z, Xie X, Sun Y, Wu H, Dai M (2020) Paeonol prevents lipid metabolism dysfunction in palmitic acid-induced HepG2 injury through promoting SIRT1-FoxO1-ATG14-dependent autophagy. Eur J Pharmacol 880:173145","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2234_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1586\/17474124.2016.1110018","volume":"10","author":"P Dongiovanni","year":"2016","unstructured":"Dongiovanni P, Rametta R, Meroni M, Valenti L (2016) The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development\u2013a potential therapeutic target? Expert Rev Gastroenterol Hepatol 10(2):229\u2013242","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5625","key":"2234_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1126\/science.1079817","volume":"300","author":"K Du","year":"2003","unstructured":"Du K, Herzig S, Kulkarni RN, Montminy M (2003) TRB3: a tribbles homolog that inhibits Akt\/PKB activation by insulin in liver. Science 300(5625):1574\u20131577","journal-title":"Science"},{"issue":"9","key":"2234_CR23","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3390\/ijms20092215","volume":"20","author":"H El Hadi","year":"2019","unstructured":"El Hadi H, Di Vincenzo A, Vettor R, Rossato M (2019) Cardio-metabolic disorders in non-alcoholic fatty liver disease. Int J Mol Sci 20(9):2215","journal-title":"Int J Mol Sci"},{"key":"2234_CR24","doi-asserted-by":"crossref","unstructured":"Ezzat SM, Jeevanandam J, Egbuna C, Kumar S, Ifemeje JC (2019) Phytochemicals as sources of drugs. In Phytochemistry: An in-silico and in-vitro Update (pp. 3\u201322). Springer, Singapore","DOI":"10.1007\/978-981-13-6920-9_1"},{"issue":"24","key":"2234_CR25","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/emboj.2010.268","volume":"29","author":"W Fan","year":"2010","unstructured":"Fan W, Morinaga H, Kim JJ, Bae E, Spann NJ, Heinz S, Glass CK, Olefsky JM (2010) FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J 29(24):4223\u20134236","journal-title":"EMBO J"},{"issue":"10","key":"2234_CR26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/nu10101366","volume":"10","author":"J Gao","year":"2018","unstructured":"Gao J, He X, Ma Y, Zhao X, Hou X, Hao E, Deng J, Bai G (2018) Chlorogenic acid targeting of the AKT PH domain activates AKT\/GSK3\u03b2\/FOXO1 signaling and improves glucose metabolism. Nutrients 10(10):1366","journal-title":"Nutrients"},{"key":"2234_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2015.11.043","volume":"770","author":"C-X Ge","year":"2016","unstructured":"Ge C-X, Yu R, Xu M-X, Li P-Q, Fan C-Y, Li J-M, Kong L-D (2016) Betaine prevented fructose-induced NAFLD by regulating LXR\u03b1\/PPAR\u03b1 pathway and alleviating ER stress in rats. Eur J Pharmacol 770:154\u2013164","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2234_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1677\/JOE-06-0191","volume":"193","author":"DA Glauser","year":"2007","unstructured":"Glauser DA, Schlegel W (2007) The emerging role of FOXO transcription factors in pancreatic \u03b2 cells. J Endocrinol 193(2):195\u2013207","journal-title":"J Endocrinol"},{"issue":"16","key":"2234_CR29","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/onc.2008.25","volume":"27","author":"D Gross","year":"2008","unstructured":"Gross D, Van den Heuvel A, Birnbaum M (2008) The role of FoxO in the regulation of metabolism. Oncogene 27(16):2320\u20132336","journal-title":"Oncogene"},{"issue":"4","key":"2234_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jnutbio.2010.12.013","volume":"23","author":"H Guo","year":"2012","unstructured":"Guo H, Xia M, Zou T, Ling W, Zhong R, Zhang W (2012) Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db\/db mice via the transcription factor FoxO1. J Nutr Biochem 23(4):349\u2013360","journal-title":"J Nutr Biochem"},{"issue":"1","key":"2234_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms6190","volume":"5","author":"RA Haeusler","year":"2014","unstructured":"Haeusler RA, Hartil K, Vaitheesvaran B, Arrieta-Cruz I, Knight CM, Cook JR, Kammoun HL, Febbraio MA, Gutierrez-Juarez R, Kurland IJ (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 5(1):1\u20138","journal-title":"Nat Commun"},{"issue":"1","key":"2234_CR32","first-page":"1","volume":"6","author":"O InSug","year":"2015","unstructured":"InSug O, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, DePinho RA, Stolz DB, Kahn CR, Schwartz MW (2015) FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun 6(1):1\u201315","journal-title":"Nat Commun"},{"issue":"4","key":"2234_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/cells9040849","volume":"9","author":"L Ioannilli","year":"2020","unstructured":"Ioannilli L, Ciccarone F, Ciriolo MR (2020) Adipose tissue and FoxO1: bridging physiology and mechanisms. Cells 9(4):849","journal-title":"Cells"},{"key":"2234_CR34","doi-asserted-by":"crossref","unstructured":"Jadeja R, Devkar RV, Nammi S (2014) Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects. Evid Based Complement Alternat Med 2014","DOI":"10.1155\/2014\/648308"},{"issue":"2","key":"2234_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmet.2007.07.003","volume":"6","author":"E Jing","year":"2007","unstructured":"Jing E, Gesta S, Kahn CR (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation\/deacetylation. Cell Metab 6(2):105\u2013114","journal-title":"Cell Metab"},{"issue":"10","key":"2234_CR36","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/mnfr.201600197","volume":"60","author":"R Kamikubo","year":"2016","unstructured":"Kamikubo R, Kai K, Tsuji-Naito K, Akagawa M (2016) \u03b2-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. Mol Nutr Food Res 60(10):2228\u20132242","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"2234_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cld.2015.10.002","volume":"20","author":"P Kanwar","year":"2015","unstructured":"Kanwar P, Kowdley KV (2015) The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clin Liver Dis 20(2):225\u2013243","journal-title":"Clin Liver Dis"},{"issue":"8","key":"2234_CR38","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2337\/db11-0770","volume":"61","author":"Y Kawano","year":"2012","unstructured":"Kawano Y, Nakae J, Watanabe N, Fujisaka S, Iskandar K, Sekioka R, Hayashi Y, Tobe K, Kasuga M, Noda T (2012) Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance. Diabetes 61(8):1935\u20131948","journal-title":"Diabetes"},{"key":"2234_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jnutbio.2017.04.014","volume":"45","author":"DH Kim","year":"2017","unstructured":"Kim DH, Kim SM, Lee B, Lee EK, Chung KW, Moon KM, An HJ, Kim KM, Yu BP, Chung HY (2017) Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome. J Nutr Biochem 45:104\u2013114","journal-title":"J Nutr Biochem"},{"issue":"36","key":"2234_CR40","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1021\/acs.jafc.6b02644","volume":"64","author":"DH Kim","year":"2016","unstructured":"Kim DH, Lee B, Kim MJ, Park MH, An HJ, Lee EK, Chung KW, Park JW, Yu BP, Choi JS (2016) Molecular mechanism of betaine on hepatic lipid metabolism: inhibition of forkhead box O1 (FoxO1) binding to peroxisome proliferator-activated receptor gamma (PPAR\u03b3). J Agric Food Chem 64(36):6819\u20136825","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2234_CR41","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/emm.2017.253","volume":"50","author":"AW Kinyua","year":"2018","unstructured":"Kinyua AW, Ko CM, Doan KV, Yang DJ, Huynh MKQ, Moh SH, Choi Y-H, Kim KW (2018) 4-hydroxy-3-methoxycinnamic acid regulates orexigenic peptides and hepatic glucose homeostasis through phosphorylation of FoxO1. Exp Mol Med 50(2):e437\u2013e437","journal-title":"Exp Mol Med"},{"key":"2234_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","volume":"6","author":"L-O Klotz","year":"2015","unstructured":"Klotz L-O, S\u00e1nchez-Ramos C, Prieto-Arroyo I, Urb\u00e1nek P, Steinbrenner H, Monsalve M (2015) Redox regulation of FoxO transcription factors. Redox Biol 6:51\u201372","journal-title":"Redox Biol"},{"issue":"11","key":"2234_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2174\/0929867013372193","volume":"8","author":"V Kren","year":"2001","unstructured":"Kren V, Mart\u00ednkov\u00e1 L (2001) Glycosides in medicine:\u201cthe role of glycosidic residue in biological activity.\u201d Current Med Chem 8(11):1303\u20131328","journal-title":"Current Med Chem"},{"issue":"12","key":"2234_CR44","first-page":"1136","volume":"4","author":"N Kucukboyaci","year":"2010","unstructured":"Kucukboyaci N, Sener B (2010) Biological activities of lignans from Taxus baccata L. growing in Turkey. J Med Plant Res 4(12):1136\u20131140","journal-title":"J Med Plant Res"},{"issue":"1\u20133","key":"2234_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2012.07.028","volume":"692","author":"Y-T Kuo","year":"2012","unstructured":"Kuo Y-T, Lin T-H, Chen W-L, Lee H-M (2012) Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells. Eur J Pharmacol 692(1\u20133):10\u201318","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"2234_CR46","doi-asserted-by":"publisher","first-page":"1801377","DOI":"10.1002\/mnfr.201801377","volume":"63","author":"H Kusu","year":"2019","unstructured":"Kusu H, Yoshida H, Kudo M, Okuyama M, Harada N, Tsuji-Naito K, Akagawa M (2019) Tomatidine reduces palmitate-induced lipid accumulation by activating AMPK via vitamin D receptor-mediated signaling in human HepG2 hepatocytes. Mol Nutr Food Res 63(22):1801377","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"2234_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.09.045","volume":"171","author":"F Langlet","year":"2017","unstructured":"Langlet F, Haeusler RA, Lind\u00e9n D, Ericson E, Norris T, Johansson A, Cook JR, Aizawa K, Wang L, Buettner C (2017) Selective inhibition of FOXO1 activator\/repressor balance modulates hepatic glucose handling. Cell 171(4):824-835.e818","journal-title":"Cell"},{"issue":"3","key":"2234_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/10409238.2011.562481","volume":"46","author":"KF Leavens","year":"2011","unstructured":"Leavens KF, Birnbaum MJ (2011) Insulin signaling to hepatic lipid metabolism in health and disease. Crit Rev Biochem Mol Biol 46(3):200\u2013215","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"15","key":"2234_CR49","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/molecules25153346","volume":"25","author":"H Lee","year":"2020","unstructured":"Lee H, Jeong JH, Ryu J-H (2020) Lignan from Alnus japonica inhibits adipocyte differentiation via cell cycle and FOXO1 regulation. Molecules 25(15):3346","journal-title":"Molecules"},{"issue":"12","key":"2234_CR50","doi-asserted-by":"publisher","first-page":"e13993","DOI":"10.1111\/jfbc.13993","volume":"45","author":"H Lee","year":"2021","unstructured":"Lee H, Lee J (2021) Anti-diabetic effect of hydroxybenzoic acid derivatives in free fatty acid-induced HepG2 cells via miR-1271\/IRS1\/PI3K\/AKT\/FOXO1 pathway. J Food Biochem 45(12):e13993","journal-title":"J Food Biochem"},{"issue":"2","key":"2234_CR51","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-17-0002","volume":"233","author":"S Lee","year":"2017","unstructured":"Lee S, Dong HH (2017) FoxO integration of insulin signaling with glucose and lipid metabolism. Jr End 233(2):R67","journal-title":"Jr End"},{"key":"2234_CR52","doi-asserted-by":"crossref","unstructured":"Li JM, Wang W, Fan CY, Wang MX, Zhang X, Hu QH, Kong LD (2013) Quercetin preserves \u03b2-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt\/FoxO1 activation. Evid Based Complement Alternat Med 2013","DOI":"10.1155\/2013\/303902"},{"key":"2234_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.taap.2018.11.001","volume":"362","author":"J Li","year":"2019","unstructured":"Li J, Wang S, Yao L, Ma P, Chen Z, Han T-L, Yuan C, Zhang J, Jiang L, Liu L (2019) 6-Gingerol ameliorates age-related hepatic steatosis: association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction. Toxicol Appl Pharmacol 362:125\u2013135","journal-title":"Toxicol Appl Pharmacol"},{"key":"2234_CR54","doi-asserted-by":"crossref","unstructured":"Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y (2018) The potential and action mechanism of polyphenols in the treatment of liver diseases. Oxid med cell longev 2018","DOI":"10.1155\/2018\/8394818"},{"key":"2234_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2017.04.002","volume":"66","author":"Y Li","year":"2017","unstructured":"Li Y, Ma Z, Jiang S, Hu W, Li T, Di S, Wang D, Yang Y (2017) A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. Prog Lipid Res 66:42\u201349","journal-title":"Prog Lipid Res"},{"issue":"16","key":"2234_CR56","doi-asserted-by":"publisher","first-page":"1900043","DOI":"10.1002\/mnfr.201900043","volume":"63","author":"Z Li","year":"2019","unstructured":"Li Z, Li Y, Zhang HX, Guo JR, Lam CWK, Wang CY, Zhang W (2019b) Mitochondria-mediated pathogenesis and therapeutics for non-alcoholic fatty liver disease. Mol Nutr Food Res 63(16):1900043","journal-title":"Mol Nutr Food Res"},{"issue":"16","key":"2234_CR57","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.7150\/thno.18788","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu Q, Zhang F-G, Zhang W-S, Pan A, Yang Y-L, Liu J-F, Li P, Liu B-L, Qi L-W (2017) Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through Akt-FoxO1 interaction. Theranostics 7(16):4001","journal-title":"Theranostics"},{"key":"2234_CR58","doi-asserted-by":"publisher","first-page":"e7668","DOI":"10.7717\/peerj.7668","volume":"7","author":"Y-z Liu","year":"2019","unstructured":"Liu Y-z, Peng W, Chen J-k, Su W-j, Yan W-j, Wang Y-x, Jiang C-l (2019) FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice. PeerJ 7:e7668","journal-title":"PeerJ"},{"issue":"5","key":"2234_CR59","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1039\/C9FO00095J","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Deng J, Fan D (2019b) Ginsenoside Rk3 ameliorates high-fat-diet\/streptozocin induced type 2 diabetes mellitus in mice via the AMPK\/Akt signaling pathway. Food Funct 10(5):2538\u20132551","journal-title":"Food Funct"},{"issue":"9","key":"2234_CR60","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/138945011796150280","volume":"12","author":"H Lu","year":"2011","unstructured":"Lu H, Huang H (2011) FOXO1: a potential target for human diseases. Curr Drug Targets 12(9):1235\u20131244","journal-title":"Curr Drug Targets"},{"issue":"7","key":"2234_CR61","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.18632\/oncotarget.23590","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu Y, Chen J, Xian T, Zhou Y, Yuan W, Wang M, Gan Y, Wang K, Xiong S, Ma C (2018) Epigallocatechin-3-gallate suppresses differentiation of adipocytes via regulating the phosphorylation of FOXO1 mediated by PI3K-AKT signaling in 3T3-L1 cells. Oncotarget 9(7):7411","journal-title":"Oncotarget"},{"key":"2234_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-020-00358-9","volume":"21","author":"Z Lu","year":"2020","unstructured":"Lu Z, He B, Chen Z, Yan M, Wu L (2020) Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway. BMC Immunol 21:1\u20139","journal-title":"BMC Immunol"},{"key":"2234_CR63","doi-asserted-by":"crossref","unstructured":"Ludwiczuk A, Skalicka-Wo\u017aniak K, Georgiev MI (2017) Terpenoids. In Pharmacognosy (pp. 233\u2013266). Academic Press","DOI":"10.1016\/B978-0-12-802104-0.00011-1"},{"issue":"9","key":"2234_CR64","first-page":"2464","volume":"116","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto M, Han S, Kitamura T, Accili D (2006) Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. Jr Clin Inv 116(9):2464\u20132472","journal-title":"Jr Clin Inv"},{"issue":"27","key":"2234_CR65","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1073\/pnas.1820282116","volume":"116","author":"T Miyauchi","year":"2019","unstructured":"Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H, Uemoto S (2019) Up-regulation of FOXO1 and reduced inflammation by \u03b2-hydroxybutyric acid are essential diet restriction benefits against liver injury. Proc Natl Acad Sci 116(27):13533\u201313542","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"2234_CR66","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00125-015-3722-5","volume":"58","author":"UB Pajvani","year":"2015","unstructured":"Pajvani UB, Accili D (2015) The new biology of diabetes. Diabetologia 58(11):2459\u20132468","journal-title":"Diabetologia"},{"key":"2234_CR67","doi-asserted-by":"publisher","first-page":"44597","DOI":"10.1038\/srep44597","volume":"7","author":"X Pan","year":"2017","unstructured":"Pan X, Zhang Y, Kim H-G, Liangpunsakul S, Dong XC (2017) FOXO transcription factors protect against the diet-induced fatty liver disease. Sci Rep 7:44597","journal-title":"Sci Rep"},{"issue":"4","key":"2234_CR68","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.pharep.2017.02.005","volume":"69","author":"A Pandey","year":"2017","unstructured":"Pandey A, Raj P, Goru SK, Kadakol A, Malek V, Sharma N, Gaikwad AB (2017) Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacol Rep 69(4):666\u2013672","journal-title":"Pharmacol Rep"},{"issue":"1","key":"2234_CR69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells9010184","volume":"9","author":"S Peng","year":"2020","unstructured":"Peng S, Li W, Hou N, Huang N (2020) A review of FoxO1-regulated metabolic diseases and related drug discoveries. Cells 9(1):184","journal-title":"Cells"},{"key":"2234_CR70","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molmet.2019.10.001","volume":"30","author":"CM Penniman","year":"2019","unstructured":"Penniman CM, Beltran PAS, Bhardwaj G, Junck TL, Jena J, Poro K, Hirshman MF, Goodyear LJ, O\u2019Neill BT (2019) Loss of FoxOs in muscle reveals sex-based differences in insulin sensitivity but mitigates diet-induced obesity. Mol Metab 30:203\u2013220","journal-title":"Mol Metab"},{"key":"2234_CR71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2019) Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism 92:82\u201397","journal-title":"Metabolism"},{"key":"2234_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2014.01.038","volume":"727","author":"P Prakash","year":"2014","unstructured":"Prakash P, Singh V, Jain M, Rana M, Khanna V, Barthwal MK, Dikshit M (2014) Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. Eur J Pharmacol 727:15\u201328","journal-title":"Eur J Pharmacol"},{"key":"2234_CR73","doi-asserted-by":"publisher","first-page":"117776","DOI":"10.1016\/j.lfs.2020.117776","volume":"254","author":"R Qi","year":"2020","unstructured":"Qi R, Jiang R, Xiao H, Wang Z, He S, Wang L, Wang Y (2020) Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor. Life Sci 254:117776","journal-title":"Life Sci"},{"issue":"9","key":"2234_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M (2020) Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis 11(9):1\u201315","journal-title":"Cell Death Dis"},{"issue":"7","key":"2234_CR75","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ijo.2012.181","volume":"37","author":"R Rametta","year":"2013","unstructured":"Rametta R, Mozzi E, Dongiovanni P, Motta B, Milano M, Roviaro G, Fargion S, Valenti L (2013) Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. Int J Obes 37(7):986\u2013992","journal-title":"Int J Obes"},{"issue":"5","key":"2234_CR76","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","volume":"52","author":"RS Rector","year":"2010","unstructured":"Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52(5):727\u2013736","journal-title":"J Hepatol"},{"issue":"6","key":"2234_CR77","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.joim.2021.09.003","volume":"19","author":"M-y Shan","year":"2021","unstructured":"Shan M-y, Dai Y, Ren X-d, Zheng J, Zhang K-b, Chen B, Yan J, Xu Z-h (2021) Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. J Integr Med 19(6):545\u2013554","journal-title":"J Integr Med"},{"key":"2234_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biocel.2017.12.019","volume":"95","author":"IC Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es IC, Fontes A, Pinton P, Zischka H, Wieckowski MR (2018) Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol 95:93\u201399","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"2234_CR79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MOL.0b013e32832b3f4c","volume":"20","author":"JD Sparks","year":"2009","unstructured":"Sparks JD, Dong HH (2009) FoxO1 and hepatic lipid metabolism. Curr Opin Lipidol 20(3):217","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"2234_CR80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/metabo10070283","volume":"10","author":"S Steensels","year":"2020","unstructured":"Steensels S, Qiao J, Ersoy BA (2020) Transcriptional regulation in non-alcoholic fatty liver disease. Metabolites 10(7):283","journal-title":"Metabolites"},{"key":"2234_CR81","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2147\/DMSO.S313068","volume":"14","author":"M Sui","year":"2021","unstructured":"Sui M, Jiang X, Sun H, Liu C, Fan Y (2021) Berberine ameliorates hepatic insulin resistance by regulating microRNA-146b\/SIRT1 pathway. Diabetes Metab Syndr Obes Targets Ther 14:2525","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"9","key":"2234_CR82","first-page":"228","volume":"3","author":"RJ Thoppil","year":"2011","unstructured":"Thoppil RJ, Bishayee A (2011) Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. Mol Nutr Food Res 3(9):228","journal-title":"Mol Nutr Food Res"},{"key":"2234_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jgh.12021","volume":"28","author":"I Tikhanovich","year":"2013","unstructured":"Tikhanovich I, Cox J, Weinman SA (2013) Forkhead box class O transcription factors in liver function and disease. J Gastroenterol Hepatol 28:125\u2013131","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"2234_CR84","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","volume":"28","author":"PM Titchenell","year":"2017","unstructured":"Titchenell PM, Lazar MA, Birnbaum MJ (2017) Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol Metab 28(7):497\u2013505","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"2234_CR85","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14(7):397","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"2234_CR86","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2337\/db07-0714","volume":"57","author":"L Valenti","year":"2008","unstructured":"Valenti L, Rametta R, Dongiovanni P, Maggioni M, Fracanzani AL, Zappa M, Lattuada E, Roviaro G, Fargion S (2008) Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57(5):1355\u20131362","journal-title":"Diabetes"},{"key":"2234_CR87","doi-asserted-by":"crossref","unstructured":"Valenti L, Riso P, Mazzocchi A, Porrini M, Fargion S, Agostoni C (2013) Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. Oxid med cell longev 2013","DOI":"10.1155\/2013\/145421"},{"issue":"4","key":"2234_CR88","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/10408398.2014.952399","volume":"57","author":"B Van De Wier","year":"2017","unstructured":"Van De Wier B, Koek GH, Bast A, Haenen GR (2017) The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Crit Rev Food Sci Nutr 57(4):834\u2013855","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"2234_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-015-0057-7","volume":"12","author":"R Vinayagam","year":"2015","unstructured":"Vinayagam R, Xu B (2015) Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr Metab 12(1):1\u201320","journal-title":"Nutr Metab"},{"key":"2234_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.foodchem.2013.09.039","volume":"146","author":"J Vinholes","year":"2014","unstructured":"Vinholes J, Rudnitskaya A, Gon\u00e7alves P, Martel F, Coimbra MA, Rocha SM (2014) Hepatoprotection of sesquiterpenoids: a quantitative structure\u2013activity relationship (QSAR) approach. Food Chem 146:78\u201384","journal-title":"Food Chem"},{"key":"2234_CR91","doi-asserted-by":"crossref","unstructured":"Wan X, Xu C, Yu C, Li Y (2016) Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Can J Gastroenterol Hepatol 2016","DOI":"10.1155\/2016\/6489012"},{"issue":"3","key":"2234_CR92","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2009.01.163","volume":"380","author":"G-L Wang","year":"2009","unstructured":"Wang G-L, Fu Y-C, Xu W-C, Feng Y-Q, Fang S-R, Zhou X-H (2009) Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1\u2013FOXO1 signaling pathway. Biochem Biophys Res Commun 380(3):644\u2013649","journal-title":"Biochem Biophys Res Commun"},{"key":"2234_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01210-0","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, He W, Tsai P-J, Chen P-H, Ye M, Guo J, Su Z (2020) Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease. Lipids Health Dis 19:1\u201319","journal-title":"Lipids Health Dis"},{"issue":"9","key":"2234_CR94","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2174\/1389450118666180516122517","volume":"19","author":"L Wang","year":"2018","unstructured":"Wang L, Chen J, Ning C, Lei D, Ren J (2018) Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic fatty liver disease (NAFLD). Curr Drug Targets 19(9):1087\u20131094. https:\/\/doi.org\/10.2174\/1389450118666180516122517","journal-title":"Curr Drug Targets"},{"issue":"5","key":"2234_CR95","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/molecules24050872","volume":"24","author":"R Wang","year":"2019","unstructured":"Wang R, Dong Z, Lan X, Liao Z, Chen M (2019) Sweroside alleviated LPS-induced inflammation via SIRT1 mediating NF-\u03baB and FOXO1 signaling pathways in RAW264.7 cells. Molecules 24(5):872","journal-title":"Molecules"},{"issue":"6","key":"2234_CR96","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.arcmed.2017.11.016","volume":"48","author":"Y Wang","year":"2017","unstructured":"Wang Y, Chen J, Kong W, Zhu R, Liang K, Kan Q, Lou Y, Liu X (2017) Regulation of SIRT3\/FOXO1 signaling pathway in rats with non-alcoholic steatohepatitis by salvianolic acid B. Arch Med Res 48(6):506\u2013512","journal-title":"Arch Med Res"},{"issue":"8","key":"2234_CR97","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW-S Wong","year":"2018","unstructured":"Wong VW-S, Adams LA, de L\u00e9dinghen V, Wong GL-H, Sookoian S (2018) Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise. Nat Rev Gastroenterol Hepatol 15(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2234_CR98","doi-asserted-by":"publisher","first-page":"e16556","DOI":"10.1371\/journal.pone.0016556","volume":"6","author":"X Xia","year":"2011","unstructured":"Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J (2011) Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 6(2):e16556","journal-title":"PLoS One"},{"issue":"1","key":"2234_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","volume":"53","author":"J Xiao","year":"2014","unstructured":"Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TYH, Fung ML, Tipoe GL (2014) Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways. Eur J Nutr 53(1):187\u2013199","journal-title":"Eur J Nutr"},{"key":"2234_CR100","doi-asserted-by":"crossref","unstructured":"Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, Wang N, Feng Y (2020) Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application. Front Pharmacol 11:601","DOI":"10.3389\/fphar.2020.00601"},{"issue":"12","key":"2234_CR101","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/mnfr.201200284","volume":"56","author":"M Yanagisawa","year":"2012","unstructured":"Yanagisawa M, Sugiya M, Iijima H, Nakagome I, Hirono S, Tsuda T (2012) Genistein and daidzein, typical soy isoflavones, inhibit TNF-\u03b1-mediated downregulation of adiponectin expression via different mechanisms in 3 T 3-L 1 adipocytes. Mol Nutr Food Res 56(12):1783\u20131793","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"2234_CR102","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/me.2015-1213","volume":"30","author":"L Yang","year":"2016","unstructured":"Yang L, Yao D, Yang H, Wei Y, Peng Y, Ding Y, Shu L (2016) Puerarin protects pancreatic \u03b2-cells in obese diabetic mice via activation of GLP-1R signaling. Mol Endocrinol 30(3):361\u2013371","journal-title":"Mol Endocrinol"},{"issue":"11","key":"2234_CR103","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jnutbio.2014.06.001","volume":"25","author":"Y Yang","year":"2014","unstructured":"Yang Y, Li W, Liu Y, Sun Y, Li Y, Yao Q, Li J, Zhang Q, Gao Y, Gao L (2014) Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1\/LKB1\/AMPK pathway. J Nutr Biochem 25(11):1207\u20131217","journal-title":"J Nutr Biochem"},{"key":"2234_CR104","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhao Y, Li W, Wu Y, Wang X, Wang Y, Liu T, Ye T, Xie Y, Cheng Z, He J, Bai P, Zhang Y, Ouyang L\u00a0(2020) Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment.\u00a0Eur J Med Chem 197:112311","DOI":"10.1016\/j.ejmech.2020.112311"},{"issue":"30","key":"2234_CR105","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","volume":"22","author":"H Yao","year":"2016","unstructured":"Yao H, Qiao Y-J, Zhao Y-L, Tao X-F, Xu L-N, Yin L-H, Qi Y, Peng J-Y (2016) Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol 22(30):6890","journal-title":"World J Gastroenterol"},{"key":"2234_CR106","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","volume":"131","author":"H Yao","year":"2018","unstructured":"Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu Y, Zheng L, Peng J (2018) Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway. Pharmacol Res 131:51\u201360","journal-title":"Pharmacol Res"},{"issue":"3","key":"2234_CR107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/1414-431X20122551","volume":"46","author":"J Yao","year":"2013","unstructured":"Yao J, Zhi M, Gao X, Hu P, Li C, Yang X (2013) Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz J Med Biol Res 46(3):270\u2013277","journal-title":"Braz J Med Biol Res"},{"key":"2234_CR108","doi-asserted-by":"crossref","unstructured":"Yu J, Marsh S, Hu J, Feng W, Wu C (2016) The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background. Gastroenterol res pract 2016","DOI":"10.1155\/2016\/2862173"},{"issue":"7","key":"2234_CR109","doi-asserted-by":"publisher","first-page":"e42115","DOI":"10.1371\/journal.pone.0042115","volume":"7","author":"X-Y Zeng","year":"2012","unstructured":"Zeng X-Y, Wang Y-P, Cantley J, Iseli TJ, Molero JC, Hegarty BD, Kraegen EW, Ye Y, Ye J-M (2012) Oleanolic acid reduces hyperglycemia beyond treatment period with Akt\/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice. PLoS One 7(7):e42115","journal-title":"PLoS One"},{"key":"2234_CR110","doi-asserted-by":"crossref","unstructured":"Zhang CH, Zhou BG, Sheng JQ, Chen Y, Cao YQ, Chen C (2020) Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacol Res 159:104984","DOI":"10.1016\/j.phrs.2020.104984"},{"issue":"3","key":"2234_CR111","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1210\/en.2015-1852","volume":"157","author":"T Zhang","year":"2016","unstructured":"Zhang T, Kim DH, Xiao X, Lee S, Gong Z, Muzumdar R, Calabuig-Navarro V, Yamauchi J, Harashima H, Wang R (2016) FoxO1 plays an important role in regulating \u03b2-cell compensation for insulin resistance in male mice. Endocrinology 157(3):1055\u20131070","journal-title":"Endocrinology"},{"issue":"1","key":"2234_CR112","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ptr.7344","volume":"36","author":"X Zhang","year":"2021","unstructured":"Zhang X, Huo Z, Luan H, Huang Y, Shen Y, Sheng L, Liang J, Wu F (2021) Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1\u03b1\/XBP1 pathway. Phytother Res 36(1):433\u2013447","journal-title":"Phytother Res"},{"issue":"40","key":"2234_CR113","doi-asserted-by":"publisher","first-page":"15899","DOI":"10.1073\/pnas.0701599104","volume":"104","author":"X Zheng","year":"2007","unstructured":"Zheng X, Yang Z, Yue Z, Alvarez JD, Sehgal A (2007) FOXO and insulin signaling regulate sensitivity of the circadian clock to oxidative stress. Proc Natl Acad Sci 104(40):15899\u201315904","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2234_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-7075-11-35","volume":"11","author":"W Zhu","year":"2014","unstructured":"Zhu W, Chen S, Li Z, Zhao X, Li W, Sun Y, Zhang Z, Ling W, Feng X (2014) Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice. Nutr Metab 11(1):1\u201311","journal-title":"Nutr Metab"},{"issue":"23","key":"2234_CR115","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.4161\/15384101.2014.965977","volume":"13","author":"P Zou","year":"2014","unstructured":"Zou P, Liu L, Zheng L, Liu L, Stoneman RE, Cho A, Emery A, Gilbert ER, Cheng Z (2014) Targeting FoxO1 with AS1842856 suppresses adipogenesis. Cell Cycle 13(23):3759\u20133767","journal-title":"Cell Cycle"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02234-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02234-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02234-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T17:04:50Z","timestamp":1668272690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02234-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":115,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2234"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02234-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare consent of participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors give consent for the publication of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}